Clinical trial
Vosoritide for Selected Genetic Causes of Short Stature
NCT04219007 is registered in ClinicalTrials.gov with Andrew Dauber as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vosoritide for Selected Genetic Causes of Short Stature
- Lead sponsor
- Andrew Dauber
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 4, 2020
- Completion date
- June 1, 2035
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
short stature